P. Tangre

Major Hypertriglyceridemia in HIV-Infected Patients on Antiretroviral Therapy: A Role of the Personal and Family History

M. Guiguet, J. Meynard, P. Benlian, 2004, Infection.

Incidence and Risk Factors of Thrombocytopenia in Patients Receiving Intermittent Antiretroviral Therapy: A Substudy of the ANRS 106-Window Trial

C. Katlama, P. Bierling, P. Morlat, 2009, Journal of acquired immune deficiency syndromes.

Intermittent antiretroviral therapy in patients with controlled HIV infection.

J. Ragnaud, J. Izopet, J. Molina, 2007, AIDS.

HIV-1-Resistant Strains during 8-Week on 8-Week off Intermittent Therapy and their Effect on CD4+ T-cell Counts and Antiviral Response

J. Izopet, J. Molina, B. Marchou, 2008, Antiviral therapy.

Presence of Lamivudine or Emtricitabine Is Associated with Reduced Emergence of Nonnucleoside Reverse Transcriptase Inhibitor Mutations in an Efavirenz-Based Intermittent Antiretroviral Treatment Regimen

J. Izopet, J. Molina, B. Marchou, 2011, Antimicrobial Agents and Chemotherapy.

Minor HIV-1 Variants with the K103N Resistance Mutation during Intermittent Efavirenz-Containing Antiretroviral Therapy and Virological Failure

Florence Nicot, Jacques Izopet, Jean-Pierre Aboulker, 2011, PloS one.

Costs of Intermittent Versus Continuous Antiretroviral Therapy in Patients With Controlled HIV Infection: A Substudy of the ANRS 106 Window Trial

I. Durand-zaleski, J. Molina, B. Marchou, 2008, Journal of acquired immune deficiency syndromes.